UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XIFR
3626
XPLR Infrastructure LP
XIFR
$1.08B
| $5.93M | ﹤0.01% |
333,011
-74,162
| -18% | -$1.48M |
|
|
SEI
3627
Solaris Energy Infrastructure
SEI
$3.55B
| $5.93M | ﹤0.01% |
205,953
+146,786
| +248% | +$2.92M |
|
3628
CALL
PPG Industries
PPG
$26.6B
| $5.92M | ﹤0.01% |
49,600
+20,000
| +68% | +$2.5M |
|
3629
Privia Health
PRVA
$2.83B
| $5.9M | ﹤0.01% |
302,035
+242,320
| +406% | +$4.8M |
|
3630
Stock Yards Bancorp
SYBT
$2.6B
| $5.9M | ﹤0.01% |
82,376
+56,053
| +213% | +$3.95M |
|
3631
CALL
Lumen
LUMN
$6.44B
| $5.9M | ﹤0.01% |
1,110,600
+289,000
| +35% | +$1.99M |
|
3632
Brady Corp
BRC
$4.57B
| $5.89M | ﹤0.01% |
79,777
+15,681
| +24% | +$1.17M |
|
3633
Sportradar
SRAD
$3.85B
| $5.88M | ﹤0.01% |
339,336
+160,508
| +90% | +$2.42M |
|
3634
CALL
TC Energy
TRP
$65.9B
| $5.88M | ﹤0.01% |
+126,400
| New | +$5.98M |
|
3635
Argan
AGX
$8.37B
| $5.88M | ﹤0.01% |
42,909
+26,727
| +165% | +$3.67M |
|
3636
Xeris Biopharma Holdings
XERS
$1.37B
| $5.88M | ﹤0.01% |
1,734,491
+1,451,239
| +512% | +$4.67M |
|
3637
CALL
AB InBev
BUD
$165B
| $5.88M | ﹤0.01% |
117,400
| – | – |
|
3638
World Kinect Corp
WKC
$1.86B
| $5.88M | ﹤0.01% |
213,654
+118,658
| +125% | +$3.4M |
|
3639
UWM Holdings
UWMC
$434M
| $5.88M | ﹤0.01% |
1,000,876
+840,558
| +524% | +$5.47M |
|
3640
First Bancorp
FBNC
$2.68B
| $5.87M | ﹤0.01% |
133,598
+103,359
| +342% | +$4.62M |
|
3641
Evertec
EVTC
$1.78B
| $5.87M | ﹤0.01% |
170,006
+109,952
| +183% | +$3.77M |
|
3642
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$531M
| $5.86M | ﹤0.01% |
63,216
+5,086
| +9% | +$474K |
|
3643
Bausch + Lomb
BLCO
$5.99B
| $5.86M | ﹤0.01% |
324,383
+316,198
| +3,863% | +$6.17M |
|
3644
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
| $5.86M | ﹤0.01% |
250,217
-19,215
| -7% | -$476K |
|
|
CVGW
3645
DELISTED
Calavo Growers
CVGW
| $5.86M | ﹤0.01% |
229,622
+219,137
| +2,090% | +$5.96M |
|
3646
Leggett & Platt
LEG
$1.31B
| $5.85M | ﹤0.01% |
609,883
+400,522
| +191% | +$4.79M |
|
3647
MYR Group
MYRG
$5.25B
| $5.85M | ﹤0.01% |
39,342
+29,098
| +284% | +$4.07M |
|
3648
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $5.85M | ﹤0.01% |
143,427
-28,482
| -17% | -$1.26M |
|
3649
PUT
CDW
CDW
$17B
| $5.85M | ﹤0.01% |
+33,600
| New | +$6.53M |
|
3650
First Industrial Realty Trust
FR
$8.44B
| $5.85M | ﹤0.01% |
116,645
-24,724
| -17% | -$1.31M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.